Alerts will be sent to your verified email
Verify EmailSANOFICONR
|
Sanofi Cons. Health
|
Alivus Life Sciences
|
Rubicon Research
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
72.87 % | 25.27 % | 5.76 % |
|
5yr average Equity Multiplier
|
1.82 | 1.74 | 2.29 |
|
5yr Average Asset Turnover Ratio
|
1.48 | 0.71 | 0.66 |
|
5yr Avg Net Profit Margin
|
27.34 % | 20.19 % | 1.04 % |
|
Price to Book
|
41.38 | 3.58 | 16.16 |
|
P/E
|
48.8 | 20.34 | 77.85 |
|
5yr Avg Cash Conversion Cycle
|
-83.69 Days | 100.66 Days | -23.11 Days |
|
Inventory Days
|
47.09 Days | 95.06 Days | 96.45 Days |
|
Days Receivable
|
10.93 Days | 132.12 Days | 88.85 Days |
|
Days Payable
|
135.97 Days | 120.47 Days | 228.02 Days |
|
5yr Average Interest Coverage Ratio
|
32.14 | 371.82 | 2.59 |
|
5yr Avg ROCE
|
99.14 % | 33.88 % | 12.78 % |
|
5yr Avg Operating Profit Margin
|
38.38 % | 29.64 % | 11.87 % |
|
5 yr average Debt to Equity
|
0.0 | 0.0 | 0.74 |
|
5yr CAGR Net Profit
|
1.88 % | 6.67 % | 34.36 % |
|
5yr Average Return on Assets
|
40.56 % | 14.28 % | 1.79 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
71.27 % | 74.91 % | 59.99 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
10.87 % | -7.94 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.28 % | 3.16 % | 0.0 |
|
Sanofi Cons. Health
|
Alivus Life Sciences
|
Rubicon Research
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|